Skip to main content
. Author manuscript; available in PMC: 2015 Oct 3.
Published in final edited form as: Cancer Discov. 2015 Jun 24;5(10):1040–1048. doi: 10.1158/2159-8290.CD-15-0274

Figure 2.

Figure 2

Summary of mutational concordance across 26 pancreatobiliary cancer patients. (A) Top: Numbers of matched biopsy DNA and plasma cfDNA samples in each patient-level concordance category. Concordant samples are those with all reported mutations found in both biopsy-based and plasma-based sequencing tests. Partial concordance occurred if at least one mutation, but not all mutations, were concordant between biopsy DNA and plasma cfDNA. TND: Tumor Not Detected. QNS: Quantity Not Sufficient. Bottom: Venn diagram showing overlap of reported mutations between cfDNA and tumor biopsy sequencing tests for 17 patients. (B) Numbers of mutations detected per gene by the cfDNA test across the cohort (49 mutations total). (C) Details of the seven non-concordant mutations from the 17 patients in (A).